Ascendis Pharma A/S (ASND)
150.82
-5.04 (-3.23%)
At close: Apr 01, 2025, 3:36 PM
13F Institute Ownership
Total Institutes of 224 in Ascendis Pharma A/S reduced their positions with a decrease of 11 investors compared to the previous quarter. An additional 1.16M shares, as total invested capital declined by $536.79M with ownership percentage increasing from 109.86% to 111.89%.
Options Activity
Institutions are holding more Puts Contracts as Calls Contracts, indicating a bearish sentiment.
Put/Call 2.717
2.72
Call Flow 78,200
27%
Put Flow 212,500
73%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Ra Capital Management, L.p. | 17.63% | 10.11M | +4.14% | 1.39B | 18.53% |
| Westfield Capital Management C... | 9.64% | 5.53M | +7.68% | 761.07M | 3.31% |
| Avoro Capital Advisors LLC | 8.90% | 5.1M | +2.29% | 702.54M | 9.94% |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.